Comparison of digital and paper-based educational interventions for common chronic respiratory diseases

Not Applicable

• Conditions: Health Condition 1: J449- Chronic obstructive pulmonary disease, unspecifiedHealth Condition 2: J452- Mild intermittent asthmaHealth Condition 3: J453- Mild persistent asthmaHealth Condition 4: J454- Moderate persistent asthmaHealth Condition 5: J459- Other and unspecified asthmaHealth Condition 6: J455- Severe persistent asthma

• Registration Number: CTRI/2022/11/047068
• Lead Sponsor: Science and Engineering Research Board (SERB)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Inclusion criteria for patients with COPD:

(1) Men and women aged <65 years with mild, moderate or severe COPD as per GOLD criteria;

(2) Resident of Chandigarh Tricity or Ambala district;

(3) Have basic digital literacy and have access to Android smart phones with internet connection;

(4) Can read and write English, Hindi or Punjabi;

(5) Consent to participate in the study.

Inclusion criteria for patients with asthma:

(1) Age 18-65 years and both sex with bronchial asthma;

(2) Resident of Chandigarh Tricity or Ambala district;

(3) Can read and write English, Hindi or Punjabi and have basic digital literacy;

(4) Have access to Android smart phones with internet connection;

(5) Ready to give written consent to participate in the study.

Exclusion Criteria

Exclusion criteria for patients with COPD:

(1) Patients with coexisting non-COPD pulmonary conditions (e.g., lung cancer, sarcoidosis, and others);

(2) Prior lung-volume reduction surgery and/or lung transplant;

(3) Long-term supplemental oxygen >=12h/day;

(4) >6 weeks of oral corticosteroids;

(5) Serious or uncontrolled comorbidities likely to interfere with the study.

Exclusion criteria for patients with asthma:

(1) Severe refractory asthma (defined as difficult to control asthma i.e., on high intensity treatment and uncontrolled asthma despite good adherence (>=80% of prescribed inhaled corticosteroids) to prescription and good inhalation technique);

(2) Presence of any active lung disease other than asthma (e.g., COPD, lung cancer, sarcoidosis, active tuberculosis, chronic pulmonary aspergillosis, bronchiectasis, allergic broncho-pulmonary aspergillosis, interstitial lung disease) or underwent lung reduction or related surgical interventions;

(3) Long-term supplemental oxygen or home NIV as these patients generally have end-stage lung disease and may not respond to our interventions;

(4) Mental impairment or language difficulties that make informed consent impossible.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life (Asthma-related or health-related for COPD)Timepoint: 3, 6, and 12 months

Secondary Outcome Measures

Name	Time	Method
Knowledge, attitude and self-efficacy practices, medication adherence, six-minute walk test, Asthma disease control (for asthma patients), Oral health status, Self-reported smoking cessation, Cost-effectiveness, Acute exacerbations, hospital visits and hospital admissions, Patientâ??s satisfaction and perspectives about the barriers and facilitators of the intervention.Timepoint: 3, 6, and 12 months